Short-term hyperoxia does not exert immunologic effects during experimental murine and human endotoxemia

Area of Science:

• Critical care medicine
• Immunology
• Physiology

Background:

• Hyperoxia, or high oxygen levels, is common in critical care and may impact patient outcomes.
• Potential immunomodulatory effects of hyperoxia are debated, with some studies suggesting anti-inflammatory properties while others indicate oxygen toxicity.

Purpose of the Study:

• To investigate whether short-term hyperoxia directly affects inflammatory responses and immune cell function.
• To differentiate between direct effects of hyperoxia and effects mediated by improved tissue oxygenation.

Main Methods:

• Exposed mice and healthy human volunteers to short-term 100% oxygen.
• Assessed inflammatory cytokine levels in the absence and presence of endotoxin-induced inflammation.
• Evaluated neutrophil phagocytosis and reactive oxygen species (ROS) generation.

Main Results:

• Short-term hyperoxia did not increase inflammatory cytokine levels in mice or humans without systemic inflammation.
• Hyperoxia did not alter the systemic inflammatory response to bacterial endotoxin.
• Neutrophil function, including phagocytosis and ROS generation, remained unaffected by short-term hyperoxia.

Conclusions:

• Hyperoxia does not appear to exert direct anti-inflammatory effects.
• The study tempers expectations for using hyperoxia as a direct immunomodulatory treatment strategy.